California Public Employees Retirement System
LRMR icon

California Public Employees Retirement System’s Larimar Therapeutics LRMR Stock Holding History

California Public Employees Retirement System’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,451
Closed -$284K – 2316
2021
Q1 		$284K Hold
19,451
– – ﹤0.01% 3247
2020
Q4 		$416K Buy
+19,451
New +$390K ﹤0.01% 3014

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

California Public Employees Retirement System's LRMR Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Larimar Therapeutics (LRMR) in Q2 2021, closing a stake of 19,451 shares — an estimated $284K sold.

California Public Employees Retirement System first reported a position in LRMR in Q4 2020 and held it in 2 quarters. The position peaked at $416K in Q4 2020. 45 funds tracked by Wall St. Rank hold LRMR as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Larimar Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 19,451 Larimar Therapeutics shares in Q2 2021, an estimated $284K.
  • California Public Employees Retirement System first reported a position in Larimar Therapeutics in Q4 2020 and held it in 2 quarters.
  • California Public Employees Retirement System's Larimar Therapeutics position peaked at $416K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.